��������

Juhong Liu is the Chief Science Officer at Evive Biotech. He is responsible for company product development and regulatory filing strategy and to ensure the most efficient approach to achieve market approval. Previously, he was the CMC Review Chief for Division II of Office of Biotechnology Products (OBP), managed and signatory of multiple CMC reviews of biopharmaceuticals reviewed by FDA.

Juhong has 14 years of experience in research on the molecular biology of cancer at the National Cancer Institute, published in top scientific journals such as “Cells”, “Molecular Cells”, “Nature-Structured Biology”.

Juhong earned a PhD in Protein Biochemistry and Molecular Biology at Peking Union Medical College.